IMMUNE AND CYTOKINE STATUS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA RECEIVING ALEMTUZUMAB

IMMUNE AND CYTOKINE STATUS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA RECEIVING ALEMTUZUMAB

In present work, we studied cytokine levels and performed analysis of some immunologic parameters in the patients with chronic lymphocytic leukemia (CLL) before and after treatment with monoclonal anti-CD52 antibody (alemtuzumab). In comparison with a control group, the CLL patients before alemtuzum...

Full description

Bibliographic Details
Main Authors:	M. N Khorobrykh, T. P. Zagoskina, V. I. Shardakov, E. L. Nazarova, A. V. Yovdiy
Format:	Article
Language:	Russian
Published:	St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists 2014-07-01
Series:	Медицинская иммунология
Subjects:	chronic lymphocytic leukemia cytokines lymphocyte subsets alemtuzumab cd52
Online Access:	https://www.mimmun.ru/mimmun/article/view/408

Similar Items

Treatment of patients with refractory chronic lymphocytic leukemia with alemtuzumab, alone or in combination with fludarabine
by: E. V. Kataeva, et al.
Published: (2014-07-01)

Treatment of patients with refractory chronic lymphocytic leukemia with alemtuzumab, alone or in combination with fludarabine
by: E. V. Kataeva, et al.
Published: (2014-07-01)

Alemtuzumab-Related Lymphocyte Subset Dynamics and Disease Activity or Autoimmune Adverse Events: Real-World Evidence
by: Elisabetta Signoriello, et al.
Published: (2023-02-01)

Alemtuzumab in treatment of chronic lymphocytic leukemia
by: S. S. Bessmeltsev, et al.
Published: (2022-11-01)

A case of effective use of alemtuzumab in a male patient with T-cell lymphoma
by: A N Sokolov, et al.
Published: (2004-12-01)

Alemtuzumab – nowy lek w terapii postaci rzutowej stwardnienia rozsianego. Pierwsza czy druga linia leczenia?
by: Jacek Zaborski
Published: (2015-11-01)

Immune Regulatory Cell Bias Following Alemtuzumab Treatment in Relapsing-Remitting Multiple Sclerosis
by: Nicole Kashani, et al.
Published: (2021-10-01)

Characteristics of lymphocyte subsets and cytokine profiles of patients with COVID-19
by: Pengfei Pan, et al.
Published: (2022-03-01)

Clinico-Biological Implications of Modified Levels of Cytokines in Chronic Lymphocytic Leukemia: A Possible Therapeutic Role
by: Alessandro Allegra, et al.
Published: (2020-02-01)

CYTOKINES, LYMPHOCYTE SUBSETS AND NEUTROPHIL PHAGOCYTOSIS ACTIVITY IN YOUNG PUERPERAL WOMEN WITH ENDOMETRITIS
by: T. E. Belokrinitskaya, et al.
Published: (2012-05-01)

Study of Bone Marrow Lymphocyte Subset in Acute Myeloid Leukemia
by: Prasad Dange, et al.
Published: (2022-06-01)

PROGNOSTIC VALUE OF TUMOR NECROSIS FACTOR-ALPHA IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
by: E. N. Zotina, et al.
Published: (2016-08-01)

Mononuclear subsets and cytokine profile of venous and capillary blood in patients with psoriasis and healthy people
by: S. V. Sennikova, et al.
Published: (2021-12-01)

T LYMPHOCYTE SUBSETS STUDIED IN A PATIENT WITH TWO ASSOCIATED HEMATOLOGIC NEOPLASIAS – CHRONIC LYMPHOCYTIC LEUKEMIA B AND CHRONIC MYELOID LEUKEMIA
by: Georgiana Ene, et al.
Published: (2019-09-01)

Gingival Leukemic Infiltration in Chronic Lymphocytic Leukemia
by: Karima Kacem, et al.
Published: (2019-11-01)

Repopulation of T, B, and NK cells following alemtuzumab treatment in relapsing-remitting multiple sclerosis
by: Wendy Gilmore, et al.
Published: (2020-06-01)

Cocaine Use Disorder Is Associated With Changes in Th1/Th2/Th17 Cytokines and Lymphocytes Subsets
by: Aline Zaparte, et al.
Published: (2019-10-01)

Anti-CD52 Therapy for Multiple Sclerosis: An Update in the COVID Era
by: Kasarello K, et al.
Published: (2021-07-01)

Cytokines and B Lymphocytes/
by: Callard, R. E.
Published: (1990)

The effect of pelvic radiation alone on lymphocyte subgroups
by: Gregory P. Swanson, et al.
Published: (2020-07-01)

Early peripheral blood lymphocyte subsets and cytokines in predicting the severity of influenza B virus pneumonia in children
by: Lu Ma, et al.
Published: (2023-05-01)

FEATURES OF IMMUNOCOMPETENT CELLS IN THE PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA AT PRIMARY DIAGNOSIS
by: N. V. Isaeva, et al.
Published: (2016-01-01)

Prediction of intravenous immunoglobulin retreatment in children with Kawasaki disease using models combining lymphocyte subset and cytokine profile in an East Asian cohort
by: Chun Zhang, et al.
Published: (2024-01-01)

Immunohistochemical analysis of CD34 to evaluate angiogenesis in chronic lymphocytic leukemia
by: Shaymaa M. Abdelateef, et al.
Published: (2013-07-01)

Changes in peripheral T-lymphocyte subsets and serum cytokines in patients with systemic sclerosis
by: Rong-Hong Guo, et al.
Published: (2022-11-01)

Clinical and immunological profile of patients with schizophrenia
by: N. Petrova, et al.
Published: (2022-06-01)

Clinical case of COVID-19 in a patient treated with alemtuzumab
by: E. V. Popova
Published: (2021-12-01)

Association of lymphocyte subsets and cytokines with bone metabolism: a retrospective, cross-sectional study
by: Cong Peng, et al.
Published: (2024-01-01)

Effects of Astragali Radix on T lymphocyte subsets expression in peripheral blood of Hashimoto′s thyroiditis patients with normal thyroid function
by: LI Ziyun, et al.
Published: (2024-01-01)

Unusual immunophenotype of T-cell large granular lymphocytic leukemia: Report of two cases
by: Nikhil Rabade, et al.
Published: (2015-01-01)

Alemtuzumab-induced thyroid eye disease successfully treated with a single low dose of rituximab
by: Ilaria Muller, et al.
Published: (2024-04-01)

Peripheral Blood Lymphocyte Subsets as a Risk Predictor of Patients with Endometrioid Endometrial Cancer
by: Su P, et al.
Published: (2022-11-01)

Meningeal involvement in chronic lymphocytic leukemia
by: S. N. Menshakova, et al.
Published: (2022-11-01)

Changes in circulating lymphocyte subpopulations in pigs receiving therapeutic doses of ceftiofur and tulathromycin
by: Czyżewska-Dors Ewelina, et al.
Published: (2016-12-01)

An immunotherapy effect analysis in Rasmussen encephalitis
by: Zuzana Liba, et al.
Published: (2020-09-01)

D-dimer levels and characteristics of lymphocyte subsets, cytokine profiles in peripheral blood of patients with severe COVID-19: A systematic review and meta-analysis
by: Haiyue Zhang, et al.
Published: (2022-10-01)

Anti-CD52 antibody treatment depletes B cell aggregates in the central nervous system in a mouse model of multiple sclerosis
by: Micha Simon, et al.
Published: (2018-08-01)

Immune reconstitution following alemtuzumab therapy is characterized by exhausted T cells, increased regulatory control of proinflammatory T cells and reduced B cell control
by: Marina Rode von Essen, et al.
Published: (2023-09-01)

CD200 Baseline Serum Levels Predict Prognosis of Chronic Lymphocytic Leukemia
by: Giovanni D’Arena, et al.
Published: (2021-08-01)

LYMPHOCYTE SUBPOPULATIONS OF BLOOD AND PLEURAL EXUDATE IN MBT-NEGATIVE AND MBT-POSITIVE TUBERCULOUS PLEURISY
by: E. A. Jureva, et al.
Published: (2014-07-01)